Wikinews

AARP claims US prescription drug prices continue to rise

There are no reviewed versions of this page, so it may not have been checked for adherence to standards.

Friday, April 15, 2005

The organization formerly known as the American Association of Retired Persons released a report claiming that prescription drug prices in the United States rose 7.1% in 2004. Overall U.S. inflation was about 3 percent in 2004.

The study covers 197 of "the brand name prescription drugs most widely used by Americans age 50 and older." The drug prices are compared on a month-by-month basis, i.e. January of 2004 is compared to January of 2003. Percentages were then averaged to arrive at quarterly and annual figures. According to the report, most of the change occurred in the first quarter of 2004; the average brand-name drug price in the first quarter of 2004 was 3.5% higher than the average price in the same quarter in 2003.

The Pharmaceutical Research and Manufacturers of America, a trade group, faults the AARP's report. For example, the trade group says medical inflation, which is greater than overall inflation in the United States, would have made a more appropriate comparison.

Three drugs increased by more than 20% in price in 2004, said the study: Premarin, Miacalcin, and Neurontin. The companies that led the way with price increases were Boehringer Ingelheim, Aventis, and Purdue Pharmaceuticals, each with average price increases of greater than 10%. Three companies increased their prices by less than 6%: Merck, GlaxoSmithKline, and Eisai, according to the study.

Sources

edit
edit
 

Share this:           


 

This page is archived, and is no longer publicly editable.

Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.

Got a correction? Add the template {{editprotected}} to the talk page along with your corrections, and it will be brought to the attention of the administrators.

Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.

Note that some listed sources or external links may no longer be available online due to age.

The text of this article is licensed under the terms of the Creative Commons Attribution 2.5 License

  This page is archived, and is no longer publicly editable.
Articles presented on Wikinews reflect the specific time at which they were written and published, and do not attempt to encompass events or knowledge which occur or become known after their publication.

Got a correction? Add the template {{editprotected}} to the talk page along with your corrections, and it will be brought to the attention of the administrators.

Please note that due to our archival policy, we will not alter or update the content of articles that are archived, but will only accept requests to make grammatical and formatting corrections.

Note that some listed sources or external links may no longer be available online due to age.

The text of this article is licensed under the terms of the Creative Commons Attribution 2.5 License
Retrieved from "https://en.wikinews.org/wiki/AARP_claims_US_prescription_drug_prices_continue_to_rise"